Overview
Paradox Neurotechnologies develops minimally invasive spinal cord stimulation systems designed to treat chronic neuropathic pain with adaptive, closed-loop feedback.
More in Neuromodulation
Latest industry news
Implanted BCIs Restore Expressive Communication for Paralyzed Clinical Trial Participants
2026-11-15 · Research
Synchron Halts BCI Trials After Device Falls Short of Performance Benchmarks
2026-11-14 · Industry
China's Brain-Computer Interface Sector Enters Clinical Reality With First Commercial Implants
2026-11-13 · Industry
Synchron Pauses Brain Implant Trials After Performance Issues Surface
2026-11-12 · Industry
Company details
Category
⚡ Neuromodulation
Location
Minneapolis, MN
Funding
Series B — $42M
Website
paradoxneuro.comListed
2026-10-26
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →